Treatment with cetuximab resulted in tumour regression after 4 days, which lasted until approximately day time 14 (when tumour started to re-grow). EGFR activation more efficiently than monovalent or bivalent
ROCK inhibitors
Treatment with cetuximab resulted in tumour regression after 4 days, which lasted until approximately day time 14 (when tumour started to re-grow). EGFR activation more efficiently than monovalent or bivalent